CSF3R and Splenomegaly: While these disease-defining mutations serve as diagnostic markers if present, the WHO also allows for the possibility of CSF3R-negative disease in the face of chronic neutrophilia, splenomegaly, and the exclusion of reactive leukocytosis38.